BACKGROUND: Human telomeres consisting of long, tandem repeats of the nucleotide sequence TTAGGG at the chromosome ends are essential for maintaining chromosomal stability. Previous epidemiologic studies have indicated that shorter telomere length in peripheral blood leukocytes (PBLs) is associated with the development of many cancers. However, the relation between PBL telomere length and the risk of soft tissue sarcoma (STS) has not been investigated. METHODS: The relative telomere length (RTL) was determined in PBLs using real-time polymerase chain reaction in this case-control study. The study participants included 137 patients with histologically confirmed STS (cases) who had received no prior chemotherapy or radiotherapy and 137 healthy controls who were frequency-matched to cases on age, sex, and ethnicity. RESULTS: Patients in the case group had significantly longer RTL than controls (1.46 ± 0.42 for cases vs 1.15 ± 0.39 for controls; P < .001). By using median RTL in the controls as a cutoff level, individuals who had long telomere length were associated with a significantly increased risk of STS compared with those who had short telomere length (adjusted odds ratio, 4.71; 95% confidence interval, 2.63-8.44). When participants were categorized further into 3 or 4 groups according to the tertile or quartile RTL values of healthy controls, a significant dose-response relation was observed between longer RTL and increased risks of STS. CONCLUSIONS: The current results provided the first epidemiologic evidence that longer telomere length in PBLs is associated significantly with an increased risk of STS, potentially suggesting an important role for telomere maintenance in STS development.
BACKGROUND:Human telomeres consisting of long, tandem repeats of the nucleotide sequence TTAGGG at the chromosome ends are essential for maintaining chromosomal stability. Previous epidemiologic studies have indicated that shorter telomere length in peripheral blood leukocytes (PBLs) is associated with the development of many cancers. However, the relation between PBL telomere length and the risk of soft tissue sarcoma (STS) has not been investigated. METHODS: The relative telomere length (RTL) was determined in PBLs using real-time polymerase chain reaction in this case-control study. The study participants included 137 patients with histologically confirmed STS (cases) who had received no prior chemotherapy or radiotherapy and 137 healthy controls who were frequency-matched to cases on age, sex, and ethnicity. RESULTS:Patients in the case group had significantly longer RTL than controls (1.46 ± 0.42 for cases vs 1.15 ± 0.39 for controls; P < .001). By using median RTL in the controls as a cutoff level, individuals who had long telomere length were associated with a significantly increased risk of STS compared with those who had short telomere length (adjusted odds ratio, 4.71; 95% confidence interval, 2.63-8.44). When participants were categorized further into 3 or 4 groups according to the tertile or quartile RTL values of healthy controls, a significant dose-response relation was observed between longer RTL and increased risks of STS. CONCLUSIONS: The current results provided the first epidemiologic evidence that longer telomere length in PBLs is associated significantly with an increased risk of STS, potentially suggesting an important role for telomere maintenance in STS development.
Authors: Patrick Schöffski; Isabelle Laure Ray-Coquard; Angela Cioffi; Nguyen Bin Bui; Sebastian Bauer; Joerg Thomas Hartmann; Anders Krarup-Hansen; Viktor Grünwald; Raf Sciot; Herlinde Dumez; Jean-Yves Blay; Axel Le Cesne; Jantien Wanders; Carolyn Hayward; Sandrine Marreaud; Monia Ouali; Peter Hohenberger Journal: Lancet Oncol Date: 2011-09-19 Impact factor: 41.316
Authors: Elissa S Epel; Jue Lin; Frank H Wilhelm; Owen M Wolkowitz; Richard Cawthon; Nancy E Adler; Christyn Dolbier; Wendy B Mendes; Elizabeth H Blackburn Journal: Psychoneuroendocrinology Date: 2005-11-17 Impact factor: 4.905
Authors: Robert Y L Zee; Amy J Castonguay; Nathaniel S Barton; Julie E Buring Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08 Impact factor: 4.254
Authors: Lisa Mirabello; Elliott G Richards; Linh M Duong; Kai Yu; Zhaoming Wang; Richard Cawthon; Sonja I Berndt; Laurie Burdett; Salma Chowdhury; Kedest Teshome; Chester Douglass; Sharon A Savage Journal: Int J Mol Epidemiol Genet Date: 2010-11-23
Authors: Xifeng Wu; Christopher I Amos; Yong Zhu; Hua Zhao; Barton H Grossman; Jerry W Shay; Sherry Luo; Waun Ki Hong; Margaret R Spitz Journal: J Natl Cancer Inst Date: 2003-08-20 Impact factor: 13.506
Authors: Monica McGrath; Jason Y Y Wong; Dominique Michaud; David J Hunter; Immaculata De Vivo Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-04 Impact factor: 4.254
Authors: Beatriz Sanchez-Espiridion; Meng Chen; Joe Y Chang; Charles Lu; David W Chang; Jack A Roth; Xifeng Wu; Jian Gu Journal: Cancer Res Date: 2014-03-11 Impact factor: 12.701
Authors: Maria M Gramatges; Qi Liu; Yutaka Yasui; M Fatih Okcu; Joseph P Neglia; Louise C Strong; Gregory T Armstrong; Leslie L Robison; Smita Bhatia Journal: Clin Cancer Res Date: 2013-11-25 Impact factor: 12.531
Authors: Matthew N Bainbridge; Georgina N Armstrong; M Monica Gramatges; Alison A Bertuch; Shalini N Jhangiani; Harsha Doddapaneni; Lora Lewis; Joseph Tombrello; Spyros Tsavachidis; Yanhong Liu; Ali Jalali; Sharon E Plon; Ching C Lau; Donald W Parsons; Elizabeth B Claus; Jill Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Kyle M Walsh; Faith G Davis; Rose Lai; Sanjay Shete; Kenneth Aldape; Christopher I Amos; Patricia A Thompson; Donna M Muzny; Richard A Gibbs; Beatrice S Melin; Melissa L Bondy Journal: J Natl Cancer Inst Date: 2014-12-07 Impact factor: 11.816